Skip to main content

Table 3 Recurrent wheezing during study period

From: Persistent recurring wheezing in the fifth year of life after laboratory-confirmed, medically attended respiratory syncytial virus infection in infancy

  

RW 2nd Year

RW 3rd Year

RW 4th Year

RW 5th Year

RW 2nd–5th Years

 

N

n

%

n

%

n

%

n

%

n

%

All children

72,602

4,091

5.6

3,492

4.8

3,466

4.8

3,380

4.7

9,151

12.6

Sex

           

 Female

35,606

1,402

3.9

1,261

3.5

1,318

3.7

1,330

3.7

3,499

9.8

 Male

36,996

2,689

7.3

2,231

6.0

2,148

5.8

2,050

5.5

5,652

15.3

Race*

           

 White

31,580

1,650

5.2

1,443

4.6

1,353

4.3

1,265

4.0

3,642

11.5

 African-American

6,454

517

8.0

409

6.3

420

6.5

441

6.8

1,093

16.9

 Asian

14,476

807

5.6

774

5.3

785

5.4

764

5.3

1,983

13.7

 Hispanic

15,189

876

5.8

644

4.2

670

4.4

664

4.4

1841

12.1

 Other/unknown

4,903

241

4.9

222

4.5

238

4.9

246

5.0

592

12.1

Maternal age, y

           

 <18

911

55

6.0

38

4.2

37

4.1

44

4.8

118

13.0

 18–34

53,125

3,068

5.8

2,530

4.8

2,571

4.8

2,453

4.6

6,779

12.8

 ≥35

18,566

968

5.2

924

5.0

858

4.6

883

4.8

2,254

12.1

Family history of asthma*

           

 None

68,824

3,698

5.4

3,131

4.5

3,135

4.6

3,053

4.4

8,320

12.1

 Father only

1,087

91

8.4

94

8.6

92

8.5

83

7.6

220

20.2

 Mother only

2,633

294

11.2

258

9.8

232

8.8

240

9.1

596

22.6

 Both parents

58

8

13.8

9

15.5

7

12.1

4

6.9

15

25.9

Sibling aged <5 y in home

           

 None

44,590

2,358

5.3

2,127

4.8

2,246

5.0

2,197

4.9

5,631

12.6

 ≥1

28,012

1,733

6.2

1,365

4.9

1,220

4.4

1,183

4.2

3,520

12.6

Congenital anomaly*

           

 Absent

67,605

3,739

5.5

3,176

4.7

3,170

4.7

3,079

4.6

8,371

12.4

 Present

4,997

352

7.0

316

6.3

296

5.9

301

6.0

780

15.6

Small for gestational age*

           

 No

71,582

4,011

5.6

3,424

4.8

3,405

4.8

3,328

4.6

8,989

12.6

 Yes

1020

80

7.8

68

6.7

61

6.0

52

5.1

162

15.9

Gestational age, wk*

           

 32–33

936

99

10.6

81

8.7

78

8.3

75

8.0

188

20.1

 34-36

4,665

401

8.6

290

6.2

294

6.3

294

6.3

793

17.0

 37

4,582

270

5.9

264

5.8

209

4.6

238

5.2

635

13.9

 38–40

51,049

2,763

5.4

2,373

4.6

2,345

4.6

2,290

4.5

6,235

12.2

 ≥41

11,370

558

4.9

484

4.3

540

4.7

483

4.2

1,300

11.4

Oxygen exposure* and BPD*

           

 No oxygen, no BPD

6,9821

3,819

5.5

3,267

4.7

3,249

4.7

3,162

4.5

8,607

12.3

 <200 h Oxygen, no BPD

2,431

221

9.1

177

7.3

165

6.8

173

7.1

445

18.3

 ≥200 h Oxygen, no BPD

300

43

14.3

34

11.3

45

15.0

36

12.0

80

26.7

 BPD

50

8

16.0

14

28.0

7

14.0

9

18.0

19

38.0

Unspecified respiratory hospitalization*

           

 None

72,345

4017

5.6

3,449

4.8

3,420

4.7

3,348

4.6

9,052

12.5

 Uncomplicated hospitalization

177

47

26.6

24

13.6

26

14.7

16

9.0

64

36.2

 Prolonged hospitalization

80

27

33.8

19

23.8

20

25.0

16

20.0

35

43.8

Laboratory-confirmed, medically attended RSV infection*

           

 None

71,336

3,829

5.4

3,326

4.7

3,312

4.6

3,280

4.6

8,748

12.3

 Outpatient

762

127

16.7

79

10.4

74

9.7

50

6.6

201

26.4

 Uncomplicated hospitalization

384

105

27.3

67

17.4

57

14.8

35

9.1

154

40.1

 Prolonged hospitalization

120

30

25.0

20

16.7

23

19.2

15

12.5

48

40.0

Laboratory-confirmed, medically attended infection with other pathogen*

           

 None

72,382

4,056

5.6

3,476

4.8

3,449

4.8

3,362

4.6

9,101

12.6

 Outpatient

119

20

16.8

7

5.9

7

5.9

8

6.7

30

25.2

 Uncomplicated hospitalization

64

7

10.9

3

4.7

5

7.8

5

7.8

10

15.6

 Prolonged hospitalization

37

8

21.6

6

16.2

5

13.5

5

13.5

10

27.0

Definite, medically attended RSV encounter in the first year of life*

           

 No

71,336

3,829

5.4

3,326

4.7

3,312

4.6

3,280

4.6

8,748

12.3

 Yes

1,266

262

20.7

166

13.1

154

12.2

100

7.9

403

31.8

  1. Abbreviations: BPD Bronchopulmonary dysplasia, RSV  Respiratory syncytial virus, RW Recurrent wheezing, wk weeks, y years.
  2. *Please refer to the appropriate section of the footnotes to Table 1 for further details.